Showing results (1851-1860 of 2,101) with videos related to
Sort By:
Pageof 211
Diabetic Medicine : a Journal of the British Diabetic Association|September 26, 2012
Elevated 1-h plasma glucose following 75-g oral glucose load is a predictor of arterial stiffness in subjects with normal glucose toleranceK Niijima, Y Muranaka, T Ando, et al.Hormone Research|March 17, 2001
Glucocorticoid effects on the diurnal rhythm of circulating leptin levelsM Nishiyama, S Makino, S Suemaru, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1987
Kinetics of [11C]N,N-dimethylphenylethylamine in mice and humans: potential for measurement of brain MAO-B activityH Shinotoh, O Inoue, K Suzuki, et al.Arerugi = [Allergy]|August 1, 1990
[Long-term follow up studies of bronchial asthma in children. II. Prognosis and complications, treatment and allergic evaluations]H Maruo, K Hashimoto, K Shimoda, et al.Arzneimittel-Forschung|January 1, 1979
Effects of niludipine (Bay a 7168) on the cardiovascular system with a note on its calcium-antagonistic effectsK Hashimoto, K Takeda, Y Katano, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological backgroundT Miura, T Fukunaga, T Igarashi, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1993
Androgen-induced growth factor and its receptor: demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cellsB Sato, H Kouhara, M Koga, et al.European Journal of Pharmacology|December 30, 1996
Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia modelsJ Arita, Y X Xue, N N Aye, et al.Arerugi = [Allergy]|July 1, 1990
[Long-term follow-up studies of bronchial asthma in children. I. Prognosis and risk factors]H Maruo, K Hashimoto, K Shimoda, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapyK Hashimoto, K Yonemori, N Katsumata, et al.Pageof 211